B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) Peptide
Our Local Distributor
北京 101111
Quick Overview for B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) Peptide (ABIN8095368)
抗原
宿主
资源
应用范围
-
-
蛋白结构域
- Middle Region
-
原理
- BCL7A Peptide - middle region
-
序列
- QENSSNSSPA PEPNSAVPSD GTEAKVDEAQ ADGKEHPGAE DASDEQNSQS
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti-BCL7A Antibody(ARP57508_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
背景
-
Background Information: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
Alternative Symbols: BCL7
-
分子量
- 25kDa
-
基因ID
- 605
-
NCBI登录号
- NP_066273
-
UniProt
- Q4VC05
抗原
-